Shuttle Pharmaceuticals Holdings (SHPH) Free Cash Flow (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Free Cash Flow of -$2.5 million in Q1 2026, down 152.14% quarter-over-quarter from -$973012.0 in Q4 2025, and up 2.91% on a YoY basis from -$2.4 million in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Free Cash Flow (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Free Cash Flow history runs 6 years deep, the most recent figure standing at -$2.5 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 2.91% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$9.4 million (down 9.2% YoY), while the FY2025 annual figure was -$9.5 million, down 29.57% from the prior year.
- Free Cash Flow was -$2.5 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from -$973012.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$355420.0 in Q2 2022 to a low of -$3.4 million in Q2 2025.
- Historically, Free Cash Flow has averaged -$1.6 million across 5 years, with a median of -$1.4 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 370.45% in 2022, then soared 63.83% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$635824.0 in 2022, then plunged by 67.05% to -$1.1 million in 2023, then tumbled by 153.27% to -$2.7 million in 2024, then jumped by 63.83% to -$973012.0 in 2025, then sank by 152.14% to -$2.5 million in 2026.
- The last three Free Cash Flow figures came in at -$2.5 million (Q1 2026), -$973012.0 (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | -2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Dec 31, 2025 | -973,012.00 |
| Dec 31, 2025 | -973,012.00 |
| Sep 30, 2025 | -2.63 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -2.53 Mn |
| Mar 31, 2025 | -2.53 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.24 Mn |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -1.06 Mn |
| Dec 31, 2023 | -1.06 Mn |